About seqWell
seqWell is a company based in Beverly (United States) founded in 2014 by Jack Leonard.. seqWell has raised $24.51 million across 6 funding rounds from investors including Codexis, Broadoak Capital Partners and Research Corporation Technologies. seqWell offers products and services including ExpressPlex™ 2.0, Tagify™, and purePlex™. seqWell operates in a competitive market with competitors including Neogen, LGC, RareCyte, Paragon Genomics and Biotangents, among others.
- Headquarter Beverly, United States
- Founders Jack Leonard
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Seqwell, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$24.51 M (USD)
in 6 rounds
-
Latest Funding Round
$3.12 M (USD), Series C
Sep 16, 2024
-
Investors
Codexis
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of seqWell
seqWell offers a comprehensive portfolio of products and services, including ExpressPlex™ 2.0, Tagify™, and purePlex™. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enables quick NGS library preparation with multiplexing for research.
Provides custom-loaded transposase for efficient genomic workflows.
Offers auto-normalization for streamlined sequencing sample processing.
Unlock access to complete
Unlock access to complete
Funding Insights of seqWell
seqWell has successfully raised a total of $24.51M across 6 strategic funding rounds. The most recent funding activity was a Series C round of $3.12 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series C — $3.1M
-
First Round
First Round
(15 Jul 2016)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2024 | Amount | Series C - seqWell | Valuation |
investors |
|
| Sep, 2023 | Amount | Series C - seqWell | Valuation |
investors |
|
| Apr, 2022 | Amount | Series C - seqWell | Valuation | Codexis |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in seqWell
seqWell has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Codexis, Broadoak Capital Partners and Research Corporation Technologies. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Research Corporation Technologies is engaged in licensing biomedical technologies.
|
Founded Year | Domain | Location | |
|
High-performance enzymes are developed for drug discovery and biotherapeutics.
|
Founded Year | Domain | Location | |
|
Investment banking services are offered in the United States.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by seqWell
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - seqWell
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Seqwell Comparisons
Competitors of seqWell
seqWell operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Neogen, LGC, RareCyte, Paragon Genomics and Biotangents, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Manufacturer of products in the areas of veterinary diagnostics, life sciences, DNA testing, and drug testing
|
|
| domain | founded_year | HQ Location |
Molecular biology reagents and services are supplied to biotech industries.
|
|
| domain | founded_year | HQ Location |
Developer of technologies for the analysis of rare and single cells in the blood
|
|
| domain | founded_year | HQ Location |
Provider of technologies and solutions genomic research and precision medicine
|
|
| domain | founded_year | HQ Location |
Veterinary diagnostics products are developed for bovine viral diarrhea testing.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Seqwell
Frequently Asked Questions about seqWell
When was seqWell founded?
seqWell was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Where is seqWell located?
seqWell is headquartered in Beverly, United States. It is registered at Beverly, Massachusetts, United States.
Is seqWell a funded company?
seqWell is a funded company, having raised a total of $24.51M across 6 funding rounds to date. The company's 1st funding round was a Series C of $7M, raised on Jul 15, 2016.
What does seqWell do?
SeqWell was founded in 2014 and is headquartered in Beverly, United States. Reagents and kits based on next-generation sequencing (NGS) technology are provided for life sciences research applications. The plexWell platform has been developed to support parallelized library preparation, enabling multiplexing of hundreds to thousands of samples. This Illumina-compatible technology facilitates increased sample throughput on benchtop NGS instruments. Operations focus on simplifying sample preparation processes in the biotechnology sector.
Who are the top competitors of seqWell?
seqWell's top competitors include Neogen, Paragon Genomics and Biotangents.
What products or services does seqWell offer?
seqWell offers ExpressPlex™ 2.0, Tagify™, and purePlex™.
Who are seqWell's investors?
seqWell has 4 investors. Key investors include Codexis, Broadoak Capital Partners, Research Corporation Technologies, and Current Investors.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.